Catherine Rowe has more than 25 years of professional experience in project management, marketing, and sales. At Greenleaf, Catherine is responsible for managing client relationships and contracts, as well as general operations, for the Medical Device and Combination Products Team.

Before joining Greenleaf in 2014, Catherine served as a Senior Project Manager in the Operations Department at The Martin Agency, a top-five global advertising firm. In this role, Catherine managed multiple projects, including planning, scheduling, and training to implement a companywide workflow software platform.

Immediately preceding her work at The Martin Agency, Catherine was the Director of Operations for Game Consulting Group LLC and Movieswap LLC, video game and movie resellers. In this role, she cultivated multiple vendor relationships while managing the corporate budget and overseeing all product logistics. During her time at Game Consulting Group, Catherine contributed to sales growth from startup to more than $6.1M.

Prior to that experience, Catherine served as an Executive Assistant for more than 12 years to the President of Phillips Sales Inc., a company that represented manufacturers specializing in consumer entertainment. While in this role, she coordinated nationwide trade shows and assisted in managing a large customer base of software retailers.

Catherine began her career as a Marketing Coordinator for Pearl Izumi, a cycling apparel company, where she executed marketing media programs and organized industry trade shows.

Catherine is a graduate of The University of Virginia.

Heather Rosecrans has more than 45 years of public health and medical device experience. She continues her commitment to public health by providing strategic consulting services and working with Greenleaf clients to bring innovative devices to the U.S.

Before joining Greenleaf, Heather served as Director of the 510(k) Premarket Notification Staff at the FDA’s Center for Devices and Radiological Health (CDRH). She was responsible for implementing administrative and regulatory policy for the 510(k) program, the 513(g) program, classification and reclassification, De Novo petitions, and other premarket regulatory requirements.

Heather started her FDA career as a biologist in the Bureau of Medical Devices. In 1980, she joined the newly organized CDRH Premarket Application (PMA) Staff. For the next seven years, she coordinated the administrative, scientific, and regulatory review of PMAs, as well as product development protocols, master files, and associated submissions.

In 1987, Heather joined the 510(k) Section of CDRH’s Program Operations Staff. In this role, she served as a Consumer Safety Officer and was a key contact for CDRH and within the FDA on 510(k) matters. Heather held this position until 1992, when she became Director of the 510(k) Staff.

Heather’s accomplishments include drafting guidance documents and regulations on the 510(k) program, training FDA staff and other stakeholders, as well as assisting in the implementation of the Medical Device User Fee Modernization Act, the Food and Drug Administration Modernization Act, and the Safe Medical Devices Act.

Heather’s extensive experience at CDRH—specifically her pivotal role in developing the 510(k) program—has made her one of the nation’s leading 510(k) experts. Since the program’s inception in 1976, the FDA has reviewed more than 150,000 device 510(k)s for a determination regarding substantial equivalence.

Heather represented CDRH in multiple forums, including national conferences, FDA advisory committee meetings, and international symposiums. While at the FDA, she worked collaboratively with the Centers for Medicare and Medicaid Services and other regulatory agencies. Her published works include numerous guidance and regulatory documents. Heather continues to speak on matters related to FDA premarket regulation of medical devices.

Heather holds a B.S. in biology from Pfeiffer College in Misenheimer, N.C.